The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm
Clinical trial NCT03558607 · UNKNOWN
Trial details
- NCT number
- NCT03558607
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2022-04-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.